ANNX
Price:
$4.71
Market Cap:
$563.29M
Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmic conditions. Central to its approach is the C1q molecule, which initiates the classical complement pathway. The company targets this pathway to address specific disease mechanisms, such as those seen in antibody-mediated autoimmune disorders and complement-driven neurodegeneration. The company's developmental pipeline features several promising candidates. ANX005, a monoclonal antibody, is in advanced clinical testing, undergoing Phase II/III trials for Guillain-Barré syndrome, as well as Phase...[Read more]
Industry
Biotechnology
IPO Date
2020-07-24
Stock Exchange
NASDAQ
Ticker
ANNX
According to Annexon, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 413.52M. This represents a change of -23.51% compared to the average of 540.63M of the last 4 quarters.
The mean historical Enterprise Value of Annexon, Inc. over the last ten years is 426.06M. The current 413.52M Enterprise Value has changed 9.61% with respect to the historical average. Over the past ten years (40 quarters), ANNX's Enterprise Value was at its highest in in the March 2026 quarter at 926.09M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
426.06M
Median
400.00M
Minimum
149.80M
Maximum
724.81M
Discovering the peaks and valleys of Annexon, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 356.84%
Maximum Annual Enterprise Value = 724.81M
Minimum Annual Increase = -75.43%
Minimum Annual Enterprise Value = 149.80M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 642.78M | -6.08% |
| 2024 | 684.36M | 356.84% |
| 2023 | 149.80M | -14.64% |
| 2022 | 175.50M | -56.12% |
| 2021 | 400.00M | 156.40% |
| 2020 | 156.00M | -75.43% |
| 2019 | 634.88M | 138.28% |
| 2018 | 266.44M | -63.24% |
The current Enterprise Value of Annexon, Inc. (ANNX) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
492.31M
5-year avg
410.49M
10-year avg
426.06M
Annexon, Inc.’s Enterprise Value is greater than DBV Technologies S.A. (366.68M), greater than Larimar Therapeutics, Inc. (122.82M), greater than Altimmune, Inc. (168.60M), greater than Korro Bio, Inc. (96.75M), greater than enGene Holdings Inc. (79.79M), less than LB Pharmaceuticals Inc Common Stock (497.78M), greater than Aura Biosciences, Inc. (343.72M), greater than Kyverna Therapeutics, Inc. (329.49M), greater than AC Immune S.A. (172.37M), greater than DiaMedica Therapeutics Inc. (299.78M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 366.68M | $416.60M | |
| 122.82M | $296.96M | |
| 168.60M | $230.35M | |
| 96.75M | $115.56M | |
| 79.79M | $82.94M | |
| 497.78M | $814.99M | |
| 343.72M | $411.52M | |
| 329.49M | $352.74M | |
| 172.37M | $235.10M | |
| 299.78M | $304.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexon, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Annexon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Annexon, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Annexon, Inc. (ANNX)?
What is the 3-year average Enterprise Value for Annexon, Inc. (ANNX)?
What is the 5-year average Enterprise Value for Annexon, Inc. (ANNX)?
How does the current Enterprise Value for Annexon, Inc. (ANNX) compare to its historical average?